NCT04530903

Brief Summary

Proctological surgery represents a short duration surgery performed in ambulatory, which causes significant post-operative pain. Post-operative pain resulting from proctological surgery is greater than 5 on the Visual Analog Scale (VAS) within the first 24 hours and it revives during the first defecation. The ideal pain management procedures are based on the multimodal analgesia model, based in turn on the combination of products and / or techniques to improve the quality of analgesia, reduce the side effects linked to the use of opioids, reduce responses to surgical stress, reduce postoperative recovery and allow rapid rehabilitation of the patient. The aim of our study is to investigate whether clonidine combined with levobupivacaine in the pudendal block reduce the total consumption of opioids in proctological surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2020

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 28, 2020

Completed
12 days until next milestone

Study Start

First participant enrolled

September 9, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

September 17, 2020

Status Verified

September 1, 2020

Enrollment Period

4 months

First QC Date

June 18, 2020

Last Update Submit

September 16, 2020

Conditions

Keywords

Post-operative PainPudendal BlockClonidineLevobupivacaine

Outcome Measures

Primary Outcomes (1)

  • Total Dose of Opioids consumed in the intraoperative period

    Total consumption of sufentanyl during the intraoperative period (in micrograms). The administration of sufentanyl depends on the change of physiological parameters (augmentation of 20% of blood pressure and/or cardiac frequency).

    up to 24 hours post-surgery

Secondary Outcomes (10)

  • Total Dose of tramadol consumed in the recovery room

    up to 24 hours post-surgery

  • Total consumption of tramadol in post-operative period

    up to 24 hours post-surgery

  • Need for tramadol administration per patient during the first 24 hours

    up to 24 hours post-surgery

  • Total Dose of piritramide consumed in the recovery room

    up to 24 hours post-surgery

  • Need for Piritramid administration per patient during the hospitalization in Post Anesthesia Care Unit (PACU)

    during the hospitalization in Post Anesthesia Care Unit (PACU)

  • +5 more secondary outcomes

Study Arms (2)

Group Clonidine

EXPERIMENTAL

Group Clonidine will benefit from the pudendal block realised with 10 ml of 0.25% levobupivacaine and 75 µg of clonidine per side.

Drug: ClonidineDrug: Levobupivacaine

Control

PLACEBO COMPARATOR

Group Control will benefit from the pudendal block realised with 10 ml of 0.25% levobupivacaine per side; 0.5 ml of 0.9% NaCl will be added to each syringe to homogenise the volume in order to remain blind.

Drug: LevobupivacaineDrug: NaCl 0.9%

Interventions

75 µg (0.5mL) per injection site

Also known as: Catapressan
Group Clonidine

0.25% (10 ml) per injection site

Also known as: Chirocaine
ControlGroup Clonidine

Nacl 0.9% (0.5ml) per injection site

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Signature of informed consent

You may not qualify if:

  • Refusal to participate ;
  • Allergy to either local anaesthetics or clonidine;
  • Local infectious pathologies (e.g. acute ano-perineal suppuration)
  • Pregnancy
  • Breastfeeding
  • Severe bradyarrhythmia due to sinus node disease or second and third degree atrioventricular block
  • Severe depressive condition
  • Severe coronary artery disease
  • Raynaud's disease
  • Heart failure
  • Obliterating thromboangiitis
  • Epilepsy
  • Spinal anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Saint-Pierre

Brussels, 1000, Belgium

RECRUITING

Related Publications (19)

  • Joshi GP. Multimodal analgesia techniques and postoperative rehabilitation. Anesthesiol Clin North Am. 2005 Mar;23(1):185-202. doi: 10.1016/j.atc.2004.11.010.

    PMID: 15763418BACKGROUND
  • Ceulemans A, De Looze D, Van de Putte D, Stiers E, Coppens M. High post-operative pain scores despite multimodal analgesia in ambulatory anorectal surgery: a prospective cohort study. Acta Chir Belg. 2019 Aug;119(4):224-230. doi: 10.1080/00015458.2018.1500802. Epub 2018 Sep 7.

    PMID: 30189793BACKGROUND
  • Joshi GP, Neugebauer EA; PROSPECT Collaboration. Evidence-based management of pain after haemorrhoidectomy surgery. Br J Surg. 2010 Aug;97(8):1155-68. doi: 10.1002/bjs.7161.

    PMID: 20593430BACKGROUND
  • Comite douleur-anesthesie locoregionale et le comite des referentiels de la Sfar. [Formalized recommendations of experts 2008. Management of postoperative pain in adults and children]. Ann Fr Anesth Reanim. 2008 Dec;27(12):1035-41. doi: 10.1016/j.annfar.2008.10.002. Epub 2008 Nov 21. No abstract available. French.

    PMID: 19026514BACKGROUND
  • Novikova N, Cluver C. Local anaesthetic nerve block for pain management in labour. Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD009200. doi: 10.1002/14651858.CD009200.pub2.

    PMID: 22513972BACKGROUND
  • Vinson-Bonnet B.. Le bloc pudendal: technique d'analgésie postopératoire en chirurgie proctologique. Pelvi-Périnéologie 2007, 2(2):180-183.

    BACKGROUND
  • Naja Z, Ziade MF, Lonnqvist PA. Nerve stimulator guided pudendal nerve block decreases posthemorrhoidectomy pain. Can J Anaesth. 2005 Jan;52(1):62-8. doi: 10.1007/BF03018582.

    PMID: 15625258BACKGROUND
  • Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006.

    PMID: 10422923BACKGROUND
  • Imbelloni LE, Vieira EM, Gouveia MA, Netinho JG, Spirandelli LD, Cordeiro JA. Pudendal block with bupivacaine for postoperative pain relief. Dis Colon Rectum. 2007 Oct;50(10):1656-61. doi: 10.1007/s10350-007-0216-7.

    PMID: 17701375BACKGROUND
  • De La Arena P.. Bloc pudendal sous échographie: faisabilité et efficacité peropératoire chez l'enfant. Annales Françaises d'Anesthésie et de Réanimation 2014; A398-A403.

    BACKGROUND
  • Gaudet-Ferrand I, De La Arena P, Bringuier S, Raux O, Hertz L, Kalfa N, Sola C, Dadure C. Ultrasound-guided pudendal nerve block in children: A new technique of ultrasound-guided transperineal approach. Paediatr Anaesth. 2018 Jan;28(1):53-58. doi: 10.1111/pan.13286. Epub 2017 Dec 5.

    PMID: 29205687BACKGROUND
  • Li A, Wei Z, Liu Y, Shi J, Ding H, Tang H, Zheng P, Gao Y, Feng S. Ropivacaine versus levobupivacaine in peripheral nerve block: A PRISMA-compliant meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017 Apr;96(14):e6551. doi: 10.1097/MD.0000000000006551.

    PMID: 28383425BACKGROUND
  • Malav K, Singariya G, Mohammed S, Kamal M, Sangwan P, Paliwal B. Comparison of 0.5% Ropivacaine and 0.5% Levobupivacaine for Sciatic Nerve Block Using Labat Approach in Foot and Ankle Surgery. Turk J Anaesthesiol Reanim. 2018 Feb;46(1):15-20. doi: 10.5152/TJAR.2017.03411. Epub 2017 Nov 27.

    PMID: 30140496BACKGROUND
  • Brummett CM, Williams BA. Additives to local anesthetics for peripheral nerve blockade. Int Anesthesiol Clin. 2011 Fall;49(4):104-16. doi: 10.1097/AIA.0b013e31820e4a49.

    PMID: 21956081BACKGROUND
  • Kirksey MA, Haskins SC, Cheng J, Liu SS. Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review. PLoS One. 2015 Sep 10;10(9):e0137312. doi: 10.1371/journal.pone.0137312. eCollection 2015.

    PMID: 26355598BACKGROUND
  • Bernard JM, Macaire P. Dose-range effects of clonidine added to lidocaine for brachial plexus block. Anesthesiology. 1997 Aug;87(2):277-84. doi: 10.1097/00000542-199708000-00014.

    PMID: 9286891BACKGROUND
  • Kelika P, Arun JM. Evaluation of clonidine as an adjuvant to brachial plexus block and its comparison with tramadol. J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun;33(2):197-202. doi: 10.4103/joacp.JOACP_58_13.

    PMID: 28781445BACKGROUND
  • Popping DM, Elia N, Marret E, Wenk M, Tramer MR. Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysis of randomized trials. Anesthesiology. 2009 Aug;111(2):406-15. doi: 10.1097/ALN.0b013e3181aae897.

    PMID: 19602964BACKGROUND
  • McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8. doi: 10.1016/j.rapm.2007.02.010.

    PMID: 17720118BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

ClonidineLevobupivacaineSodium Chloride

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

ImidazolinesImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsBupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Panayota Kapessidou, MD,PhD

    University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)

    STUDY DIRECTOR
  • Myriam Suball, MD

    University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)

    PRINCIPAL INVESTIGATOR
  • Marzia Gambassi, MD

    University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Panayota Kapessidou, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2020

First Posted

August 28, 2020

Study Start

September 9, 2020

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

September 17, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations